Forth Management

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2020	Pear Therapeutics	$80.0M Series D	Elena Viboch	f7 Ventures, General Catalyst, 5AM Ventures, Arboretum Ventures, CrimsoNox Capital, EDBI, JAZZ Venture Partners, Novartis, Pilot House Ventures, QUAD Investment Management, Sarissa Capital, Shanda Group, Temasek

Total Raised

N/A

Valuation

N/A